Chemical Structure (Clobazam 01)
Clobazam Suspension
Product Images NDC 68094-074
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 68094-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Clobazam 02)
Figure 2 (Clobazam 03)
This text contains data related to the proportion of patients in different categories and the reduction in weekly drop seizure frequency from baseline. It appears to be a comparison between placebo and three different levels of Clobazam (Low, Medium, High). The reduction in seizure frequency is categorized in different ranges from 0 to less than 20, 20 to less than 40, 40 to less than 60, 60 to less than 80, and 80 to 100.*
Principal Display Panel (4 mL Syringe Label)
This is information about cloBAZam Oral Suspension, a medication for oral administration. The text provides instructions to shake the syringe well before each use and to store the product at 20-25°C (68-77°F). The packaging is from Precision Dose, Inc. located in Beloit, Illinois 61080.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
